Abstract:INTRODUCTION: Mutations in the GFPT1 gene are associated with a particular subtype of congenital myasthenia syndrome (CMS) called limb-girdle myasthenia with tubular aggregates. However, not all patients show tubular aggregates in muscle biopsy, suggesting the diversity of myopathology should be further investigated.METHODS: In this study, we reported two unrelated patients clinically characterized by easy fatigability, limb-girdle muscle weakness, positive decrements of repetitive stimulation, and response to pyridostigmine. The routine examinations of myopathology were conducted. The causative gene was explored by whole-exome screening. In addition, we summarized all GFPT1-related CMS patients with muscle biopsy in the literature.RESULTS: Pathogenic biallelic GFPT1 mutations were identified in the two patients. In patient one, muscle biopsy indicated vacuolar myopathic changes and atypical pathological changes of myofibrillar myopathy characterized by desmin deposits, Z-disc disorganization, and electronic dense granulofilamentous aggregation. In patient two, muscle biopsy showed typical myopathy with tubular aggregates. Among the 51 reported GFPT1-related CMS patients with muscle biopsy, most of them showed tubular aggregates myopathy, while rimmed vacuolar myopathy, autophagic vacuolar myopathy, mitochondria-like myopathy, neurogenic myopathy, and unspecific myopathic changes were also observed in some patients. These extra-synaptic pathological changes might be associated with GFPT1-deficiency hypoglycosylation and altered function of muscle-specific glycoproteins, as well as partly responsible for the permanent muscle weakness and resistance to acetylcholinesterase inhibitor therapy.CONCLUSIONS: Most patients with GFPT1-related CMS had tubular aggregates in the muscle biopsy, but some patients could show great diversities of the pathological change. The myopathological findings might be a biomarker to predict the prognosis of the disease.

Molecular Interaction Between Fukutin and Pomgnt1 in the Glycosylation Pathway of Alpha-Dystroglycan

Fukutin Gene Retrotransposal Insertion in A Non-Japanese Fukuyama Congenital Muscular Dystrophy (fcmd) Patient

Founder Mutation Causes Classical Fukuyama Congenital Muscular Dystrophy (FCMD) in Chinese Patients

Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies

Analysis of Phenotype, Enzyme Activity and Genotype of Chinese Patients with POMT1 Mutation.

[Analysis of GFM1 Gene Mutations in a Family with Combined Oxidative Phosphorylation Deficiency 1].

Phenotype and Genotype Study of Chinese POMT2-Related α-Dystroglycanopathy

Novel POMGnT1 Mutations Cause Muscle-Eye-brain Disease in Chinese Patients

Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro

Deletion of Brain Dystroglycan Recapitulates Aspects of Congenital Muscular Dystrophy

POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan

Congenital Disorder of Glycosylation Type 1T with a Novel Truncated Homozygous Mutation in PGM1 Gene and Literature Review.

Genetic Variations and Clinical Spectrum of Dystroglycanopathy in a Large Cohort of Chinese Patients.

Removal of pomt1 in zebrafish leads to loss of α-dystroglycan glycosylation and dystroglycanopathy phenotypes

Recognition of EGF-like Domains by the Notch-modifying O-fucosyltransferase POFUT1

Diverse myopathological features in the congenital myasthenia syndrome with GFPT1 mutation

A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)

Analysis of endogenous NOTCH1 from patient fibroblasts reveals the importance of the -fucose modification on EGF12 in human development

Just Expect It: Compound Heterozygous Variants of POMT1 in a Consanguineous Family—The Role of Next Generation Sequencing in Neuromuscular Disorders

Dysferlin Mutation in a Chinese Pedigree with Miyoshi Myopathy.

Clinical Exome Sequencing Identifies Novel Compound Heterozygous Mutations of the POMT2 Gene in Patients with Limb‐girdle Muscular Dystrophy